Airfinity Limited
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, Airfinity learned that there are bigger, more urgent questions the industry as a whole is struggling to answer: what is happening in a given therapy area right now and what is potentially next? Scientific conferences are an important source of this information, but only one among many. As a company, we realised that as an increasing amount of data became open and novel RWE data sources emerged, there was an opportunity to improve the intelligence driving key decisions in the life science space by not only connecting and linking these disparate and complex data sources but through advanced data science transform them into real-time actionable insights.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Medical / Health Care
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2015
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Airfinity provides global health intelligence and analytics that decision makers can trust, understand and act upon to save lives.
In 2017, we significantly expanded our data collection capabilities and in 2019 started offering a broader science intelligence solution with the aim of building the one go-to-place for real-time, predictive health analytics. Initially our focus was cardio-vascular diseases but soon certain areas of oncology were also added. This more ambitious purpose also had a personal angle; in 2018, Founder and CEO Rasmus Bech Hansen lost his mother to cancer after a 9-year battle during which he saw the desperate need for potential new treatments. In retrospect, Rasmus has said the experience instilled both him and the company with a stronger purpose; an urgency and realisation that better information can save lives.
When COVID-19 emerged in early 2020, we quickly saw that our proprietary technology and expertise perfectly positioned us to help the world better navigate an unprecedented situation. Across a sleepless few months the company built the world's first dedicated COVID-19 health analytics and intelligence platform which is now the trusted source of decision makers and media globally. Our data and forecasts have made a material difference to the global response to COVID-19; they have helped save lives.
Today, Airfinity is one of the fastest growing health data companies, serving clients on all major continents. Our hope is to continue to improve and find better ways to use data to empower decision makers to address more of humanity's big challenges.
What We Do
Disease-centric solutions combine proprietary surveillance tools and forecast models with expert analysis to produce actionable insights across pipeline developments, standard of care, regulatory trends, market access and supply and demand.
Global infectious disease and pre-emptive health intelligence
Airfinity offers a comprehensive suite of world-leading market intelligence solutions, turning disconnected data points into real time predictive indicators.
By linking data points and building up historical correlation models, we can provide near real time data driven assessments of the impact of a new development. Bottom-up forecasts are built by subject matter experts who analyse, commentate and contextualise all our data through platform insights, searchable reports and regular in-person briefings.
Disease Outcomes
Monitor infection rates and trends, vaccine coverage and disease impact globally and regionally.
A disease centric platform to monitor and predict disease development, prevalence and protection levels.
Risk Surveillance
Monitor pathogenic threats in real time and identify populations at highest risk of new outbreaks.
Independent risk frameworks provide country-level rankings by analysing outbreaks and disease dynamics.
New Science
Assess, predict and compare the value and future performance of candidates within a given therapy area.
A competitor intelligence solution providing therapy and compound centric pipeline surveillance and predictions.
Commercial
Anticipate production, demand and market growth for a given therapy area.
A commercial intelligence solution providing insight and predictions into country level revenue, market size and market share per drug class.